VJHemOnc is committed to improving our service to you

MPN Advances Day 2019 | Avapritinib updates in advanced systemic mastocytosis: EXPLORER and PIONEER

VJHemOnc is committed to improving our service to you

Mark Drummond

Mark Drummond, MB ChB, PhD, FRCPath, Beatson West of Scotland Cancer Centre, Glasgow, UK, discusses the novel therapies for systemic mastocytosis. He explains the results thus far for the EXPLORER trial of avapritinib in patients with advanced symstemic mastocytosis (NCT02561988), and mentions the upcoming PIONEER trial (NCT03731260). This interview took place at the Myeloproliferative Neoplasms Conference 2019 in London, UK.

Share this video  

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter